Navidea Biopharmaceuticals, Inc (NAVB) Financials
NAVB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 5.7 million | 8.7 million |
2023-06-30 | 8.2 million | 9.0 million |
2023-03-31 | 2.4 million | 11.9 million |
2022-12-31 | 4.4 million | 12.5 million |
NAVB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -10.3 million | 10347 |
2023-06-30 | 4.6 million | -33842 |
2023-03-31 | -1.8 million | 19669 |
2022-12-31 | -2.5 million | 34895 |
NAVB Net Income
No data available :(
NAVB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 3.9 million | - | 10696 |
2023-06-30 | 6.1 million | - | 19564 |
2023-03-31 | 33795 | - | 11298 |
2022-12-31 | 2.0 million | - | 20288 |
NAVB Shares Outstanding
NAVB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 16523 | 829613 | 1.3 million | - |
2023-06-30 | 65337 | 1.1 million | 1.3 million | - |
2023-03-31 | 39409 | 1.3 million | 1.2 million | - |
2022-12-31 | 72039 | 1.9 million | 1.3 million | - |
NAVB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | 610 | 50036 |
NAVB
Price: $0.04
52 week price:
Earnings Per Share: -0.20 USD
P/E Ratio: -0.17
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 89200
Market Capitalization: 4.0 million